NEW beclometasone / formoterol / glycopyrronium
PBS LISTING
THINK
TRIP
E
*
THINK
TRIMBOW1
NEW beclometasone / formoterol / glycopyrronium
PBS LISTING
FOR SEVERE ASTHMA ( 100 / 6 / 10 ) 2
* Trimbow is the only triple therapy PBS listed for severe asthma in two strengths and COPD ( 100 / 6 / 10 ) 2
Trimbow 100 / 6 / 10 & 200 / 6 / 10 are indicated for maintenance treatment ; in adults with asthma not adequately controlled with a maintenance combination of medium dose or high dose ICS / LABA respectively , and who experienced ≥1 exacerbation ( s ) in the previous year . Trimbow 100 / 6 / 10 is indicated in adults with moderate to severe COPD who are not adequately treated by ICS / LABA or LABA / LAMA . 1
New PBS listing for severe asthma - Trimbow 100 / 6 / 10 ( medium ICS strength ) 2
PBS listed for severe asthma - Trimbow 200 / 6 / 10 ( high ICS strength ) 2 PBS listed for COPD - Trimbow 100 / 6 / 10 ( medium ICS strength ) 2
PBS Information : Trimbow Authority required ( STREAMLINED ). Severe Asthma . Chronic Obstructive Pulmonary Disease ( 100 / 6 / 10 mcg presentation only ). Criteria Apply . Refer to PBS for full information .
COPD : chronic obstructive pulmonary disease ; ICS : inhaled corticosteroid ; LABA : long-acting beta 2 agonist ; LAMA : long-acting muscarinic antagonist ; PBS : Pharmaceutical Benefits Scheme . References : 1 . Approved Trimbow Product Information . 2 . Pharmaceutical Benefits Scheme . www . pbs . gov . au . Chiesi Australia Pty Ltd , Hawthorn East , VIC . 3123 , Australia . Email : medinfo . au @ chiesi . com ; Website : www . chiesi . com . au . Copyright © Chiesi 2025 . All rights reserved . January 2025 . AU-RES-2500017 CHIE00211B .